Entera Bio (ENTX) Receivables - Net (2018 - 2025)

Entera Bio has disclosed Receivables - Net across 7 years of filings, most recently posting $126000.0 for Q1 2025.

• Quarterly Receivables - Net changed N/A year-over-year to $126000.0 in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $126000.0 (changed N/A YoY) and the FY2024 annual result came in at $126000.0, changed N/A from the prior year.
• Receivables - Net steadied at $126000.0 in Q1 2025, from $126000.0 in the prior quarter.
• Over five years, Receivables - Net peaked at $246000.0 in Q4 2022 and troughed at $29000.0 in Q1 2023.
• A 5-year average of $136909.1 and a median of $126000.0 in 2024 frame the typical range for Receivables - Net.
• Annual changes were most pronounced in 2023 — Receivables - Net slumped 87.11% — and 2024, when it jumped 96.55%.
• Tracing ENTX's Receivables - Net over 5 years: stood at $183000.0 in 2021, then jumped by 34.43% to $246000.0 in 2022, then plunged by 88.21% to $29000.0 in 2023, then soared by 334.48% to $126000.0 in 2024, then changed by 0.0% to $126000.0 in 2025.
• Business Quant data shows ENTX's Receivables - Net at $126000.0 in Q1 2025, $126000.0 in Q4 2024, and $42000.0 in Q3 2024.